Robert C. Doebele, MD, PhD, discusses resistance in patients with ROS1-positive lung cancer.
Videos
HER2+ Early-Stage Breast Cancer: Perioperative Approaches
Andrew Zhu, MD, PhD, director of Liver Cancer Research and Medicine at Massachusetts General Hospital, shares his advice on making decisions for frontline treatment of patients with hepatocellular carcinoma.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
2
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
3
Melanoma Survival Is Tied to Comorbidity Burden, Illuminating Care Opportunities
4
MVR-T3011 Yields Efficacy and Safety in BCG-Unresponsive NMIBC
5
